300439.SZ · 美康生物
China A-shares · RS rating 93 · As of 2026-10-14
| Price | 10.06 CNY |
|---|---|
| 1-day change | -1.5% |
| RS rating (overall / 1M / 3M / 12M) | 93 / 91 / 90 / 67 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 40 / 33 / 48 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +20.2% |
| Distance from 52-week high | +8.9% |
| Market cap (USD) | $591.8M |